recall
saveLannett Company Inc. recall (Cls II)
December 11, 2024updated 5mo ago
community read0 votes
Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37 — Reason: Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity. — Status: Terminated
view source ↗Data sources
last refreshed 5m ago
Found something off?
same company · ±60 days · 4
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalOct 31, 2024
- approvalacetaminophen ER: OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalOct 31, 2024
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalOct 31, 2024
- approvalORLYNVAH (PROBENECID) — FDA approvalOct 25, 2024
🐶 often sniffed alongside
top 8- tagApproval218 co-mentions · 109 sources
- tagSmall Molecule91 co-mentions · 91 sources
- drugMETADATE CD84 co-mentions · 42 sources
- drugMETADATE ER84 co-mentions · 42 sources
- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN74 co-mentions · 28 sources
- drugmethylphenidate hydrochloride ER42 co-mentions · 42 sources
- drugmethylphenidate ER42 co-mentions · 42 sources
- drugmethylphenidate42 co-mentions · 42 sources
comments(0)
5-min edit window · permanent after that